18 research outputs found

    ATEROGENESIS

    Get PDF
    La aterosclerosis humana es un proceso patológico complejo, de causa multifactorial, compuesto de dos fenómenos estrechamente relacionados: la aterosis, que se caracteriza por la acumulación de lípidos tanto intra como extracelularmente y que incluye la formación de las llamadas células espumosas y reacción inflamatoria; y la esclerosis, que es el endurecimiento cicatrizal de la pared arterial, caracterizado por el incremento de miocitos, distrofia de la matriz extracelular, calcificación, necrobiosis y mayor reacción inflamatoria. El endotelio es quizá el órgano más grande del cuerpo con funciones endócrinas, autócrinas y parácrinas. Realiza varias funciones, entre las que se hallan, la regulación del intercambio de moléculas entre la sangre y la pared vascular; controla el tono vascular a través del óxido nítrico y la prostaglandina I2, causando relajación del músculo liso vascular, así como también, desarrolla funciones antitrombóticas-fibrinolíticas entre otras. Un factor fundamental en la aterosclerosis es la disfunción endotelial, cuyo aspecto clave es la disminución del óxido nítrico, la cual pudiera deberse a un aumento en su degradación metabólica ó bien, a una reducción en su síntesis. De igual importancia es la participación de las lipoproteínas de baja densidad (LDL), que en condiciones de disfunción endotelial, permanecen un tiempo mayor en el espacio subendotelial, donde son oxidadas (modificadas),originando las LDL mínimamente modificadas (MM-LDL).Las células que participan directamente en la formación de la placa ateromatosa son los monocitos, que al madurar en el espacio subendotelial se convierten en macrófagos. Por otro lado, las MM-LDL se exponen a un mayor grado de oxidación y son capaces de estimular ó activar al macrófago, el cual, al no contar con un mecanismo que limite la entrada de colesterol, degrada pobremente a las LDL oxidadas. A consecuencia de la incorporación no controlada de colesterol, el macrófago se ceba y se convierte en una célula espumosa, la cual al morir, los lípidos restantes formarán el núcleo ateromatoso junto con sustancias tóxicas, las que lesionarán al endotelio, que pasa de presentar una disfunción sin anomalías morfológicas hasta ser un endotelio dañado, que en algunas zonas puede inclusive, ser destruido y desaparecer. La exposición de este endotelio no funcional a la sangre del colágeno subyacente, estimula la adhesión plaquetaria, las que en conjunto con los macrófagos secretan factores de crecimiento, que terminan por estimular la proliferación y migración de células musculares lisas de la capa media.Palabras claves: aterogenesis, ateroma, aterosclerosis humanaatherogenesis, atheroma, human atherosclerosi

    OBESIDAD Y TEJIDO ADIPOSO

    Get PDF
    La etiología de la Obesidad es multifactorial, se contempla actualmente como una enfermedad crónica que afecta a todos los grupos poblacionales y está ligada a las principales causas de enfermedades crónicodegenerativas. Se ha comprobado que surge de un exceso en la ingesta calóriaca contra un  escaso gasto  energético  propiciado por el sedentarismo y la sobrealimentación, situaciones que promueven la  formación de tejido adiposo. Hoy en día se define al tejido adiposo como una  glándula de secreción interna que sirve como reservorio de energía  y participa activamente en el equilibrio metabólico. El tejido adiposo constituye, en cantidad, el mayor órgano de la economía corporal, el cual tiene un potencial de crecimiento ilimitado a cualquier edad.  Abstract The etiology of obesity is multifactorial, currently it is viewed as a chronic disease that affects all poblational groups and it is tied to the main causes of chronic o degenerative diseases.  It is well documented that it arises from an excess in caloric intake against a scare energetic output, caused by sedentarism and overeating, both situations promote adipose tissue formation.Nowaday adipose tissue is defined as an internal secretory gland that acts as an energy reservoir and it actively participates in the metabolic balance. Adipose tissue constitutes, from a quantity, standpoint the biggest organ in the body economy and it has the potential for unlimited growth at any age. Palabras clave: Obesidad; tejido adiposo, adipocito

    Role of age and comorbidities in mortality of patients with infective endocarditis

    Get PDF
    [Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

    Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

    Full text link
    The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

    Patients with Crohn's disease have longer post-operative in-hospital stay than patients with colon cancer but no difference in complications' rate

    Get PDF
    BACKGROUNDRight hemicolectomy or ileocecal resection are used to treat benign conditions like Crohn's disease (CD) and malignant ones like colon cancer (CC).AIMTo investigate differences in pre- and peri-operative factors and their impact on post-operative outcome in patients with CC and CD.METHODSThis is a sub-group analysis of the European Society of Coloproctology's prospective, multi-centre snapshot audit. Adult patients with CC and CD undergoing right hemicolectomy or ileocecal resection were included. Primary outcome measure was 30-d post-operative complications. Secondary outcome measures were post-operative length of stay (LOS) at and readmission.RESULTSThree hundred and seventy-five patients with CD and 2,515 patients with CC were included. Patients with CD were younger (median = 37 years for CD and 71 years for CC (P &lt; 0.01), had lower American Society of Anesthesiology score (ASA) grade (P &lt; 0.01) and less comorbidity (P &lt; 0.01), but were more likely to be current smokers (P &lt; 0.01). Patients with CD were more frequently operated on by colorectal surgeons (P &lt; 0.01) and frequently underwent ileocecal resection (P &lt; 0.01) with higher rate of de-functioning/primary stoma construction (P &lt; 0.01). Thirty-day post-operative mortality occurred exclusively in the CC group (66/2515, 2.3%). In multivariate analyses, the risk of post-operative complications was similar in the two groups (OR 0.80, 95%CI: 0.54-1.17; P = 0.25). Patients with CD had a significantly longer LOS (Geometric mean 0.87, 95%CI: 0.79-0.95; P &lt; 0.01). There was no difference in re-admission rates. The audit did not collect data on post-operative enhanced recovery protocols that are implemented in the different participating centers.CONCLUSIONPatients with CD were younger, with lower ASA grade, less comorbidity, operated on by experienced surgeons and underwent less radical resection but had a longer LOS than patients with CC although complication's rate was not different between the two groups

    Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Get PDF
    Background: Patients infected with influenza A (H1N1)pdm09 virus requiring admission to the ICU remain an important source of mortality during the influenza season. The objective of the study was to assess the impact of a delay in diagnosis of community-acquired influenza A (H1N1)pdm09 virus infection on clinical outcome in critically ill patients admitted to the ICU. Methods: A prospective multicenter observational cohort study was based on data from the GETGAG/SEMICYUC registry (2009–2015) collected by 148 Spanish ICUs. All patients admitted to the ICU in which diagnosis of influenza A (H1N1)pdm09 virus infection had been established within the first week of hospitalization were included. Patients were classified into two groups according to the time at which the diagnosis was made: early (within the first 2 days of hospital admission) and late (between the 3rd and 7th day of hospital admission). Factors associated with a delay in diagnosis were assessed by logistic regression analysis. Results: In 2059 ICU patients diagnosed with influenza A (H1N1)pdm09 virus infection within the first 7 days of hospitalization, the diagnosis was established early in 1314 (63.8 %) patients and late in the remaining 745 (36.2 %). Independent variables related to a late diagnosis were: age (odds ratio (OR) = 1.02, 95 % confidence interval (CI) 1.01–1.03, P < 0.001); first seasonal period (2009–2012) (OR = 2.08, 95 % CI 1.64–2.63, P < 0.001); days of hospital stay before ICU admission (OR = 1.26, 95 % CI 1.17–1.35, P < 0.001); mechanical ventilation (OR = 1.58, 95 % CI 1.17–2.13, P = 0.002); and continuous venovenous hemofiltration (OR = 1.54, 95 % CI 1.08–2.18, P = 0.016). The intra-ICU mortality was significantly higher among patients with late diagnosis as compared with early diagnosis (26.9 % vs 17.1 %, P < 0.001). Diagnostic delay was one independent risk factor for mortality (OR = 1.36, 95 % CI 1.03–1.81, P < 0.001). Conclusions: Late diagnosis of community-acquired influenza A (H1N1)pdm09 virus infection is associated with a delay in ICU admission, greater possibilities of respiratory and renal failure, and higher mortality rate. Delay in diagnosis of flu is an independent variable related to death

    Role of age and comorbidities in mortality of patients with infective endocarditis.

    No full text
    The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups: A total of 3120 patients with IE (1327  There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in th

    Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse

    No full text

    Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    No full text

    The impact of stapling technique and surgeon specialism on anastomotic failure after right?sided colorectal resection: an international multicentre, prospective audit

    Get PDF
    Aim There is little evidence to support choice of technique and configuration for stapled anastomoses after right hemicolectomy and ileocaecal resection. This study aimed to determine the relationship between stapling technique and anastomotic failure. Method Any unit performing gastrointestinal surgery was invited to contribute data on consecutive adult patients undergoing right hemicolectomy or ileocolic resection to this prospective, observational, international, multicentre study. Patients undergoing stapled, side?to?side ileocolic anastomoses were identified and multilevel, multivariable logistic regression analyses were performed to explore factors associated with anastomotic leak. Results One thousand three hundred and forty?seven patients were included from 200 centres in 32 countries. The overall anastomotic leak rate was 8.3%. Upon multivariate analysis there was no difference in leak rate with use of a cutting stapler for apical closure compared with a noncutting stapler (8.4% vs 8.0%, OR 0.91, 95% CI 0.54–1.53, P = 0.72). Oversewing of the apical staple line, whether in the cutting group (7.9% vs 9.7%, OR 0.87, 95% CI 0.52–1.46, P = 0.60) or noncutting group (8.9% vs 5.7%, OR 1.40, 95% CI 0.46–4.23, P = 0.55) also conferred no benefit in terms of reducing leak rates. Surgeons reporting to be general surgeons had a significantly higher leak rate than those reporting to be colorectal surgeons (12.1% vs 7.3%, OR 1.65, 95% CI 1.04–2.64, P = 0.04). Conclusion This study did not identify any difference in anastomotic leak rates according to the type of stapling device used to close the apical aspect. In addition, oversewing of the anastomotic staple lines appears to confer no benefit in terms of reducing leak rates. Although general surgeons operated on patients with more high?risk characteristics than colorectal surgeons, a higher leak rate for general surgeons which remained after risk adjustment needs further exploration
    corecore